01875.HK
BioDlink International Company Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.31
−0.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 265.80x
- P/E 2027E
- 37.44x
- P/E 2028E
- 29.21x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.32x
- Price / sales
- 4.07x
- Price / cash flow
- -30.88x
Enterprise value
- Enterprise value
- HKD 2.5B
- EV / sales
- 4.25x
- EV / EBITDA
- -51.73x
- EV / EBIT
- -13.85x
- Market cap
- HKD 2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026